These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16810405)

  • 21. Treatment selections of 239 patients with blepharospasm and Meige syndrome over 11 years.
    Mauriello JA; Dhillon S; Leone T; Pakeman B; Mostafavi R; Yepez MC
    Br J Ophthalmol; 1996 Dec; 80(12):1073-6. PubMed ID: 9059273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Involuntary facial movements, not all medication-induced.
    Kaufman DM
    Am J Psychiatry; 1992 Aug; 149(8):1124-5. PubMed ID: 1353320
    [No Abstract]   [Full Text] [Related]  

  • 23. Tardive Meige syndrome responsive to clozapine.
    Van Putten T; Wirshing WC; Marder SR
    J Clin Psychopharmacol; 1990 Oct; 10(5):381-2. PubMed ID: 1979568
    [No Abstract]   [Full Text] [Related]  

  • 24. Successful therapy of tardive dyskinesia in a 71-year-old woman with a combination of tetrabenazine, olanzapine and tiapride.
    Koch HJ; Szecsey A; Vogel M; Fischer-Barnicol D
    Int J Clin Pract; 2003 Mar; 57(2):147-9. PubMed ID: 12661802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Botulinum toxin in painful tardive dyskinesia.
    Tschopp L; Salazar Z; Micheli F
    Clin Neuropharmacol; 2009; 32(3):165-6. PubMed ID: 19483486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Laryngeal dystonia].
    Barbosa ER
    Arq Neuropsiquiatr; 2001 Sep; 59(3-B):829. PubMed ID: 11593295
    [No Abstract]   [Full Text] [Related]  

  • 27. The use of botulinum toxin in head and neck disorders.
    Hawthorne MR
    Hosp Med; 2003 Aug; 64(8):460-3. PubMed ID: 12958756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preventing contractures [correction of contractions] in neuroleptic malignant syndrome and dystonia.
    Black KJ; Racette B; Perlmutter JS
    Am J Psychiatry; 1998 Sep; 155(9):1298-9. PubMed ID: 9734560
    [No Abstract]   [Full Text] [Related]  

  • 29. Efficacy of risperidone in idiopathic segmental dystonia.
    Zuddas A; Cianchetti C
    Lancet; 1996 Jan; 347(8994):127-8. PubMed ID: 8538330
    [No Abstract]   [Full Text] [Related]  

  • 30. Chemodenervation with botulinum toxin for spasticity and dystonia. The effects on gait.
    O'Brien CF
    Adv Neurol; 2001; 87():265-9. PubMed ID: 11347231
    [No Abstract]   [Full Text] [Related]  

  • 31. Botulinum toxin treatment of occupational and focal hand dystonia.
    Karp BI
    Mov Disord; 2004 Mar; 19 Suppl 8():S116-9. PubMed ID: 15027063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Idiopathic focal dystonia of the foot in a 98-year-old-woman. Treatment with botulin toxin].
    Verlhac B; Dobigny-Roman N; Forette B
    Presse Med; 1996 Dec; 25(40):2042. PubMed ID: 9082380
    [No Abstract]   [Full Text] [Related]  

  • 33. Botulinum toxin in a case of severe tardive dyskinesia mixed with dystonia.
    Stip E; Faughnan M; Desjardin I; Labrecque R
    Br J Psychiatry; 1992 Dec; 161():867-8. PubMed ID: 1362371
    [No Abstract]   [Full Text] [Related]  

  • 34. Blepharospasm, Meige syndrome, and hemifacial spasm: treatment with botulinum toxin.
    Mauriello JA
    Neurology; 1985 Oct; 35(10):1499-500. PubMed ID: 4033932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical application of botulinum toxin].
    Grandas F
    Neurologia; 1995; 10(6):224-33. PubMed ID: 7546812
    [No Abstract]   [Full Text] [Related]  

  • 36. Use of botulinum toxin in Meige's disease.
    Maurri S; Brogelli S; Alfieri G; Barontini F
    Riv Neurol; 1988; 58(6):245-8. PubMed ID: 3247565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Botulinum toxin treatment in clinical neurology.
    Van den Bergh P
    Acta Neurol Belg; 1995; 95(2):70-9. PubMed ID: 7618431
    [No Abstract]   [Full Text] [Related]  

  • 38. Botulinum toxin treatment of axial and cervical dystonia.
    Benecke R; Dressler D
    Disabil Rehabil; 2007 Dec; 29(23):1769-77. PubMed ID: 18033602
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Botulinum toxin--from threat to cure].
    Odergren T; Lennerstrand G; Lindestad PA; Hertegård S; Borg J
    Lakartidningen; 1996 Apr; 93(17):1619-24. PubMed ID: 8667769
    [No Abstract]   [Full Text] [Related]  

  • 40. [Future prospects for botulinum toxin therapy].
    Kaji R
    Nihon Naika Gakkai Zasshi; 2006 Sep; 95(9):1895-9. PubMed ID: 17037333
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.